Works by Yoichi Kobayashi


Results: 107
    1
    2
    3
    4
    5
    6

    A qualitative systematic review of the significance of adjuvant therapy in patients with low-risk endometrial cancer presenting positive peritoneal cytology: a relevant study to the guideline update for endometrial cancer by the Japan society of gynecologic oncology guideline committee

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 2, p. 217, doi. 10.1093/jjco/hyad140
    By:
    • Shigeta, Shogo;
    • Konno, Yosuke;
    • Terai, Yoshito;
    • Morisada, Tohru;
    • Tokunaga, Hideki;
    • Baba, Tsukasa;
    • Kobayashi, Yoichi;
    • Nagase, Satoru
    Publication type:
    Article
    7
    8
    9
    10

    Significance of Hypophosphatemia in Patients with Pneumonia.

    Published in:
    Internal Medicine, 2022, v. 61, n. 7, p. 979, doi. 10.2169/internalmedicine.6949-20
    By:
    • Yasuhiro Morimoto;
    • Takashi Ishiguro;
    • Ryuji Uozumi;
    • Kenji Takano;
    • Yoichi Kobayashi;
    • Yasuhito Kobayashi;
    • Yoshihiko Shimizu;
    • Noboru Takayanagi
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan.

    Published in:
    International Journal of Clinical Oncology, 2014, v. 19, n. 6, p. 1074, doi. 10.1007/s10147-014-0669-3
    By:
    • Morikawa, Asuka;
    • Ueda, Kazu;
    • Takahashi, Kazuaki;
    • Fukunaga, Masaharu;
    • Iwashita, Mitsutoshi;
    • Kobayashi, Yoichi;
    • Takechi, Kimihiro;
    • Umezawa, Satoshi;
    • Terauchi, Fumitoshi;
    • Kiguchi, Kazushige;
    • Aoki, Daisuke;
    • Nomura, Hiroyuki;
    • Yoshikawa, Hiroyuki;
    • Satoh, Toyomi;
    • Jobo, Toshiko;
    • Fujiwara, Hiroyuki;
    • Takei, Yuji;
    • Kamoi, Seiryu;
    • Terao, Yasuhisa;
    • Isonishi, Seiji
    Publication type:
    Article
    27
    28
    29

    A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non‐small cell lung cancer.

    Published in:
    Thoracic Cancer, 2021, v. 12, n. 9, p. 1387, doi. 10.1111/1759-7714.13915
    By:
    • Isono, Taisuke;
    • Kagiyama, Naho;
    • Shibata, Shun;
    • Nakajima, Hitomi;
    • Matsui, Yuma;
    • Takano, Kenji;
    • Nishida, Takashi;
    • Hosoda, Chiaki;
    • Kawate, Eriko;
    • Kobayashi, Yoichi;
    • Ishiguro, Takashi;
    • Takaku, Yotaro;
    • Kurashima, Kazuyoshi;
    • Yanagisawa, Tsutomu;
    • Takayanagi, Noboru
    Publication type:
    Article
    30

    Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors.

    Published in:
    Thoracic Cancer, 2021, v. 12, n. 2, p. 153, doi. 10.1111/1759-7714.13736
    By:
    • Isono, Taisuke;
    • Kagiyama, Naho;
    • Takano, Kenji;
    • Hosoda, Chiaki;
    • Nishida, Takashi;
    • Kawate, Eriko;
    • Kobayashi, Yoichi;
    • Ishiguro, Takashi;
    • Takaku, Youtaro;
    • Kurashima, Kazuyoshi;
    • Yanagisawa, Tsutomu;
    • Takayanagi, Noboru
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50